360iResearch Logo
Canada Companion Diagnostics Market
Report Code: MRR-151BB0E | Publishing Date: September 2020 | Number of Pages: 94
FEATURED COMPANIES

The Canada Companion Diagnostics Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the Canada Companion Diagnostics Market.

Market Segmentation & Coverage:

The research report categorizes the Companion Diagnostics Market to forecast the revenues and analyze the trends in each of the following segments:

Based on Technology, the Companion Diagnostics Market studied across Immunohistochemistry, In Situ Hybridization, Next-generation Sequencing, and Polymerase Chain Reaction.

Based on Indication, the Companion Diagnostics Market studied across Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, and Melanoma.

Based on End User, the Companion Diagnostics Market studied across Biopharmaceutical Companies, Pharmaceutical, and Reference Laboratories.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch Competitive Strategic Window:

The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

360iResearch FPNV Positioning Matrix:

The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Companion Diagnostics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Research Process
      1. Define: Research Objective
      2. Determine: Research Design
      3. Prepare: Research Instrument
      4. Collect: Data Source
      5. Analyze: Data Interpretation
      6. Formulate: Data Verification
      7. Publish: Research Report
      8. Repeat: Report Update
    2. Research Execution
      1. Initiation: Research Process
      2. Planning: Develop Research Plan
      3. Execution: Conduct Research
      4. Verification: Finding & Analysis
      5. Publication: Research Report
    3. Research Outcome
  3. Executive Summary
    1. Introduction
    2. Market Outlook
    3. Technology Outlook
    4. Indication Outlook
    5. End User Outlook
    6. Competitor Outlook
  4. Market Overview
    1. Introduction
  5. Market Dynamics
    1. Introduction
    2. Drivers
    3. Restraints
    4. Opportunities
    5. Challenges
  6. Canada Companion Diagnostics Market, By Technology
    1. Introduction
    2. Immunohistochemistry
    3. In Situ Hybridization
    4. Next-generation Sequencing
    5. Polymerase Chain Reaction
  7. Canada Companion Diagnostics Market, By Indication
    1. Introduction
    2. Breast Cancer
    3. Colorectal Cancer
    4. Leukemia
    5. Lung Cancer
    6. Melanoma
  8. Canada Companion Diagnostics Market, By End User
    1. Introduction
    2. Biopharmaceutical Companies
    3. Pharmaceutical
    4. Reference Laboratories
  9. Competitive Landscape
    1. FPNV Positioning Matrix
      1. Quadrants
      2. Business Strategy
      3. Product Satisfaction
    2. Market Ranking Analysis
    3. Market Share Analysis
    4. Competitive Scenario
      1. Merger & Acquisition
      2. Agreement, Collaboration, & Partnership
      3. New Product Launch & Enhancement
      4. Investment & Funding
      5. Award, Recognition, & Expansion
  10. Company Usability Profiles
  11. Appendix
    1. Discussion Guide

List of Tables

  1. CANADA COMPANION DIAGNOSTICS MARKET SIZE, 2017-2025 (USD MILLION)
  2. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  3. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  4. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  5. CANADA COMPANION DIAGNOSTICS MARKET: SCORES
  6. CANADA COMPANION DIAGNOSTICS MARKET: BUSINESS STRATEGY
  7. CANADA COMPANION DIAGNOSTICS MARKET: PRODUCT SATISFACTION
  8. CANADA COMPANION DIAGNOSTICS MARKET: RANKING
  9. CANADA COMPANION DIAGNOSTICS MARKET: MERGER & ACQUISITION
  10. CANADA COMPANION DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  11. CANADA COMPANION DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  12. CANADA COMPANION DIAGNOSTICS MARKET: INVESTMENT & FUNDING
  13. CANADA COMPANION DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION

List of Figures

  1. CANADA COMPANION DIAGNOSTICS MARKET: RESEARCH PROCESS
  2. CANADA COMPANION DIAGNOSTICS MARKET: RESEARCH EXECUTION
  3. CANADA COMPANION DIAGNOSTICS MARKET SIZE, 2019 VS 2025 (USD MILLION)
  4. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (USD MILLION)
  5. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  6. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2019 VS 2025 (USD MILLION)
  7. CANADA COMPANION DIAGNOSTICS MARKET SIZE, 2017-2025 (USD MILLION)
  8. CANADA COMPANION DIAGNOSTICS MARKET: MARKET DYNAMICS
  9. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (%)
  10. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (USD MILLION)
  11. COMPETITIVE STRATEGIC WINDOW FOR CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025
  12. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2017-2025 (USD MILLION)
  13. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2017-2025 (USD MILLION)
  14. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2017-2025 (USD MILLION)
  15. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2025 (USD MILLION)
  16. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2019 VS 2025 (%)
  17. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  18. COMPETITIVE STRATEGIC WINDOW FOR CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025
  19. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, 2017-2025 (USD MILLION)
  20. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, 2017-2025 (USD MILLION)
  21. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY LEUKEMIA, 2017-2025 (USD MILLION)
  22. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, 2017-2025 (USD MILLION)
  23. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY MELANOMA, 2017-2025 (USD MILLION)
  24. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2019 VS 2025 (%)
  25. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2019 VS 2025 (USD MILLION)
  26. COMPETITIVE STRATEGIC WINDOW FOR CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY END USER, 2025
  27. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2017-2025 (USD MILLION)
  28. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL, 2017-2025 (USD MILLION)
  29. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, 2017-2025 (USD MILLION)
  30. CANADA COMPANION DIAGNOSTICS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
  31. CANADA COMPANION DIAGNOSTICS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
  32. COMPETITIVE SCENARIO ANALYSIS IN CANADA COMPANION DIAGNOSTICS MARKET, BY TYPE